
Company valuation, historical trends, and peer comparisons.
According to argenx SE’s latest financial reports and current stock price. The company's current Enterprise Value is 54.17B. This represents a change of 82.40% compared to the average of 29.70B of the last 4 quarters.
The mean historical Enterprise Value of argenx SE over the last ten years is 14.82B. The current 54.17B Enterprise Value has changed 265.45% with respect to the historical average. Over the past ten years (40 quarters), ARGX's Enterprise Value was at its highest in in the June 2026 quarter at 46.92B. The Enterprise Value was at its lowest in in the December 2013 quarter at -31373415.00.
Average
14.82B
Median
12.55B
Minimum
205.46M
Maximum
40.49B
Discovering the peaks and valleys of argenx SE Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 417.63%
Maximum Annual Enterprise Value = 40.49B
Minimum Annual Increase = -3.00%
Minimum Annual Enterprise Value = 205.46M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 40.49B | 7.56% |
| 2024 | 37.64B | 113.78% |
| 2023 | 17.61B | -3.00% |
| 2022 | 18.15B | 18.57% |
| 2021 | 15.31B | 56.50% |
| 2020 | 9.78B | 87.35% |
| 2019 | 5.22B | 90.31% |
| 2018 | 2.74B | 157.98% |
| 2017 | 1.06B | 417.63% |
| 2016 | 205.46M | 49.02% |
The current Enterprise Value of argenx SE (ARGX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
31.91B
5-year avg
25.84B
10-year avg
14.82B
argenx SE’s Enterprise Value is less than UCB S.A. (56.70B), greater than Genmab A/S (36.91B), greater than Incyte Corporation (21.80B), less than RemeGen Co. Ltd. Class A (54.48B), less than Celltrion, Inc. (51.72T), greater than Biogen Inc. (44.11B), greater than TG Therapeutics, Inc. (9.71B), less than Alteogen Inc. (14.89T), less than Amgen Inc. (299.50B), greater than Ipsen S.A. (11.88B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 56.70B | $53.88B | |
| 36.91B | $220.01B | |
| 21.80B | $25.04B | |
| 54.48B | $55.16B | |
| 51.72T | $48.93T | |
| 44.11B | $37.61B | |
| 9.71B | $9.43B | |
| 14.89T | $14.86T | |
| 299.50B | $258.68B | |
| 11.88B | $12.89B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like argenx SE using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like argenx SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is argenx SE's Enterprise Value?
What is the highest Enterprise Value for argenx SE (ARGX)?
What is the 3-year average Enterprise Value for argenx SE (ARGX)?
What is the 5-year average Enterprise Value for argenx SE (ARGX)?
How does the current Enterprise Value for argenx SE (ARGX) compare to its historical average?